Mar 27, 2015 9:12am EDT Phase 3 Data Supporting Rayaldee™ As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at NKF 2015 Spring Clinical Meetings
Mar 06, 2015 8:30am EST Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference
Mar 03, 2015 9:31am EST Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference
Feb 26, 2015 10:30am EST OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015
Feb 20, 2015 12:37pm EST OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test
Feb 13, 2015 12:13pm EST OPKO Health to Present at the 2015 RBC Capital Markets’ Healthcare Conference